Corpus vs INDmoney: Which Should Manage Your Mutual Fund Decisions? (2026)

One is a super-app that shows you everything you own. The other is a decision engine that tells you what to fix. Here's the honest breakdown.

Short answer: INDmoney and Corpus solve different problems, and comparing them as rivals misses the point. If you want one app to see everything (Indian stocks, US stocks, mutual funds, FDs, EPF, net worth), INDmoney is one of the best trackers built in India. If you want to know what's wrong with your mutual fund portfolio, and what to do about the commission leaks, fund overlap, idle cash, and unclaimed tax breaks it finds, that's Corpus's entire job.

This page exists because people keep asking us "should I use Corpus instead of INDmoney?" The honest answer is usually "that's not the choice you're making." Below: what each one does, where each is better, and when using both makes sense.

What INDmoney Actually Is

INDmoney is a financial super-app with over 10 million users. Its core promise is breadth: one dashboard for your Indian stocks, thousands of US stocks (with zero-fee deposits and withdrawals), direct mutual funds, fixed deposits, IPOs, EPF, credit cards, insurance, and a family-level net worth view. For US stock access from India, it's one of the smoothest routes available.

It's free to use. Like most free super-apps, it earns through distribution and cross-selling: brokerage on stock trades, and revenue from placing financial products like fixed deposits, loans, and insurance. That's a legitimate model, and INDmoney is transparent about its regulated entities. Its broking arm INDstocks Private Limited is a SEBI-registered stock broker and AMFI-registered mutual fund distributor, and the group also holds a SEBI investment adviser registration under Finzoom Investment Advisors.

Where INDmoney shines:

• Net worth in one place. Nothing else in India aggregates this many asset classes this smoothly, including your family's accounts.
• US stocks. Fractional investing in thousands of US names, folded into the same dashboard.
• Direct MF investing. You can buy direct plans through the app, so those transactions carry no distributor commission trail.

Where it's thinner: analysis depth. INDmoney shows you your holdings and returns. It doesn't sit down with your transaction history and tell you that lot #14 of your flexi-cap fund crosses the 12-month LTCG threshold next month, or that three of your five funds hold the same eleven stocks.

What Corpus Actually Is

Corpus is not a tracker. It's a decision engine for mutual fund portfolios. You upload your CAMS or KFintech consolidated statement, and it works at the FIFO transaction-lot level (every purchase, every unit, every date) to answer one question: what should you do next?

Concretely, a Corpus review computes and flags:

• Your true XIRR: money-weighted return across every transaction, not the point-to-point number a factsheet shows.
• Regular-plan commission leaks. Regular plans carry a 0.5–1.2% higher expense ratio than the identical direct plan. On a ₹25 lakh portfolio, that's roughly ₹18,000–25,000 leaving your account every year, compounding against you.
• Fund overlap. Owning six funds that all hold the same large-cap names is one fund's risk with six funds' paperwork.
• Idle cash sitting in savings accounts earning less than inflation.
• LTCG harvesting opportunities: which specific lots you can sell and rebuy to use the ₹1.25 lakh annual LTCG exemption, computed per lot with exit loads and STCG/LTCG classification handled.

On top of the review sits an AI assistant that answers questions on your actual data, like "which of my funds dragged my XIRR down?", plus daily ratings on 955+ funds.

The business model is the sharpest difference: Corpus is free and earns no commission from any AMC, broker, or insurer. Nothing on the platform pays Corpus to be recommended. The planned revenue model is fee-only advice once its SEBI RIA registration, currently in progress, is granted. Until that registration comes through, everything Corpus produces is educational analysis: it will show you the math on your portfolio, but it does not issue specific buy or sell recommendations.

Where Corpus is thinner: it doesn't track US stocks, credit cards, or insurance, and it isn't a place to execute trades. It's a diagnosis tool, not a dashboard you open daily.

Head to Head

The Incentive Question

This is a structural fact about every free financial app, ours included, not a knock on INDmoney.

A platform that earns from distribution has a mild, persistent pull toward the products that pay it. Its tracking stays honest; INDmoney's dashboard shows your numbers accurately. But the app's suggestions live inside a business model where "buy this FD" or "take this loan" generates revenue and "do nothing, your portfolio is fine" does not.

Corpus's model has the opposite shape: since nothing pays us, the review can say "exit this fund," "switch your regular plans to direct," or "you don't need to buy anything this month" without losing a rupee. The trade-off: Corpus has to earn your trust enough that some users eventually pay for advice directly, a harder business than distribution. You, the reader, benefit from knowing which pull each app operates under.

A Worked Example: What Depth Looks Like

Say you hold ₹25 lakh across five funds, three of them regular plans bought through a bank RM in 2019.

In INDmoney, you'd see the five funds, their current value, and returns. A clean, accurate picture. Whether the plans are regular or direct is visible if you look, but nothing quantifies the cost.

In a Corpus review, the same portfolio produces a different output: the three regular plans carry expense ratios 0.7–1.1% above their direct twins, which on your ₹16 lakh in those funds means roughly ₹14,000 a year in trail commission flowing to a distributor for zero ongoing service. Two of your five funds overlap 62% by holdings. And four purchase lots totalling ₹3.8 lakh in gains have crossed the LTCG line; harvesting ₹1.25 lakh of that this financial year saves ₹15,625 in future tax at the 12.5% LTCG rate. Total identified: about ₹30,000 in the first year alone, before compounding.

Same portfolio. One app described it; the other diagnosed it. That's the entire difference in one paragraph.

The Honest Verdict

Use INDmoney if your main problem is fragmentation (assets scattered across brokers, AMCs, and banks), or if US stocks are part of your plan. As a consolidated view of your financial life, it's good, and it costs you nothing to keep.

Use Corpus if your main problem is uncertainty: you suspect your portfolio has leaks, overlap, or missed tax breaks, but no app has ever told you plainly. A review takes one CAMS upload and usually surfaces real rupees.

If you only take one action from this page, make it this: pull your CAMS statement and find out what your current portfolio is quietly costing you. That number is knowable in about five minutes, and it's free.